Cyclin-dependent kinase 4

CDK4
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCDK4, CMM3, PSK-J3, cyclin-dependent kinase 4, cyclin dependent kinase 4
External IDsOMIM: 123829; MGI: 88357; HomoloGene: 55429; GeneCards: CDK4; OMA:CDK4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_052984
NM_000075

NM_009870
NM_001355005

RefSeq (protein)

NP_000066

NP_034000
NP_001341934

Location (UCSC)Chr 12: 57.75 – 57.76 Mbn/a
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

Cyclin-dependent kinase 4 (CDK4), also known as cell division protein kinase 4, is an enzyme that is encoded by the CDK4 gene in humans. CDK4 is a member of the cyclin-dependent kinase family, a group of serine/threonine kinases which regulate the cell cycle.[4] CDK4 regulates the G1/S transition by contributing to the phosphorylation of retinoblastoma (RB) protein, which leads to the release of protein factors like E2F1 that promote S-phase progression.[5] It is regulated by cyclins like cyclin D proteins, regulatory kinases, and cyclin kinase inhibitors (CKIs).[5] Dysregulation of the CDK4 pathway is common in many cancers, and CDK4 is a new therapeutic target in cancer treatment.[6]

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000135446Ensembl, May 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ Hives M, Jurecekova J, Holeckova KH, Kliment J, Sivonova MK (2023). "The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors". Bratislavske Lekarske Listy. 124 (4): 261–266. doi:10.4149/BLL_2023_039. PMID 36598318.
  5. ^ a b Baker SJ, Reddy EP (November 2012). "CDK4: A Key Player in the Cell Cycle, Development, and Cancer". Genes & Cancer. 3 (11–12): 658–669. doi:10.1177/1947601913478972. PMC 3636745. PMID 23634254.
  6. ^ Sobhani N, D'Angelo A, Pittacolo M, Roviello G, Miccoli A, Corona SP, et al. (April 2019). "Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer". Cells. 8 (4): 321. doi:10.3390/cells8040321. PMC 6523967. PMID 30959874.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne